IRIS Accounts Production v24.3.0.553 05469634 Board of Directors 1.7.23 30.6.24 30.6.24 Medium entities 0 0 true false true true false false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh054696342023-06-30054696342024-06-30054696342023-07-012024-06-30054696342022-06-30054696342022-07-012023-06-30054696342023-06-3005469634ns15:EnglandWales2023-07-012024-06-3005469634ns14:PoundSterling2023-07-012024-06-3005469634ns10:Director12023-07-012024-06-3005469634ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3005469634ns10:MediumEntities2023-07-012024-06-3005469634ns10:Audited2023-07-012024-06-3005469634ns10:Medium-sizedCompaniesRegimeForDirectorsReport2023-07-012024-06-3005469634ns10:Medium-sizedCompaniesRegimeForAccounts2023-07-012024-06-3005469634ns10:FullAccounts2023-07-012024-06-300546963412023-07-012024-06-3005469634ns10:OrdinaryShareClass12023-07-012024-06-3005469634ns10:Director22023-07-012024-06-3005469634ns10:Director32023-07-012024-06-3005469634ns10:CompanySecretary12023-07-012024-06-3005469634ns10:RegisteredOffice2023-07-012024-06-3005469634ns5:CurrentFinancialInstruments2024-06-3005469634ns5:CurrentFinancialInstruments2023-06-3005469634ns5:ShareCapital2024-06-3005469634ns5:ShareCapital2023-06-3005469634ns5:SharePremium2024-06-3005469634ns5:SharePremium2023-06-3005469634ns5:RetainedEarningsAccumulatedLosses2024-06-3005469634ns5:RetainedEarningsAccumulatedLosses2023-06-3005469634ns5:ShareCapital2022-06-3005469634ns5:RetainedEarningsAccumulatedLosses2022-06-3005469634ns5:SharePremium2022-06-3005469634ns5:RetainedEarningsAccumulatedLosses2022-07-012023-06-3005469634ns5:RetainedEarningsAccumulatedLosses2023-07-012024-06-3005469634ns5:NetGoodwill2023-07-012024-06-300546963412023-07-012024-06-3005469634ns5:ReportableOperatingSegment12023-07-012024-06-3005469634ns5:ReportableOperatingSegment12022-07-012023-06-3005469634ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2023-07-012024-06-3005469634ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2022-07-012023-06-3005469634ns15:UnitedKingdom2023-07-012024-06-3005469634ns15:UnitedKingdom2022-07-012023-06-3005469634ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2023-07-012024-06-3005469634ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2022-07-012023-06-3005469634ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2023-07-012024-06-3005469634ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2022-07-012023-06-3005469634ns5:NetGoodwill2023-06-3005469634ns5:NetGoodwill2024-06-3005469634ns5:NetGoodwill2023-06-3005469634ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3005469634ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-3005469634ns5:CurrentFinancialInstruments2023-07-012024-06-3005469634ns10:OrdinaryShareClass12024-06-3005469634ns5:RetainedEarningsAccumulatedLosses2023-06-3005469634ns5:SharePremium2023-06-30
REGISTERED NUMBER: 05469634 (England and Wales)















STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024

FOR

ARABELLA HEALTH STAFFING LIMITED

ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024










Page

Company Information 1

Strategic Report 2

Report of the Directors 5

Report of the Independent Auditors 7

Income Statement 11

Other Comprehensive Income 12

Balance Sheet 13

Statement of Changes in Equity 14

Notes to the Financial Statements 15


ARABELLA HEALTH STAFFING LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2024







DIRECTORS: I J Ellis
C L Rees
P M Streeter





SECRETARY: N Patel





REGISTERED OFFICE: Ambition House, 92-96 Lind Road
Sutton
Surrey
SM1 4PL





REGISTERED NUMBER: 05469634 (England and Wales)





AUDITORS: Belluzzo Audit Limited
Chartered Accountants and Statutory Auditors
38 Craven Street
London
WC2N 5NG

ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

STRATEGIC REPORT
FOR THE YEAR ENDED 30 JUNE 2024


The directors present their strategic report for the year ended 30 June 2024.

REVIEW OF BUSINESS
Overall, the results are in line with directors' expectations. As shown by the results for the year, the company continues to trade profitably with improved margins and costs carefully controlled. In line with other businesses operating in this market there remains the commercial risk around the lack of visibility of earnings in the future demand for agency staff.

The balance sheet remains strong with net assets standing at £8,500,561 (2023: £8,413,753) and access to appropriate cash reserves from retained earnings through group treasury arrangements. Otherwise there are no significant changes in the composition of balance sheet.

PRINCIPAL RISKS AND UNCERTAINTIES
Principal risks and uncertainties facing the company are similar to those of any other trading company operating in markets in which the company operates. Within these confines management do what they can do to manage commercial risk factors.


ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

STRATEGIC REPORT
FOR THE YEAR ENDED 30 JUNE 2024

SECTION 172(1) STATEMENT
The companies (Miscellaneous reporting) regulations 2018 require directors to explain how they consider the interests of key stakeholders and the broader matters set out in section 172(1) A to (F) of the Companies Act. This section describes how the directors have had regard to these matters in exercising their duty to promote the success of the company for the benefit of its members.

- s172(1)(A) The likely consequence of any decision in the long term

The strategy is to build quality, businesses, organically, by exploring expanding new markets that are allied to the companies existing core business whilst retaining strong, net assets and cash reserves. During the year, this has required a balance between capital expenditure and enhancing facilities whilst remaining alert to the risks being posed by Changes in buyer behaviours.

-s172(1)(B) the interest of the company's employees

There is a company-wide commitment to treating employees fairly and respectfully. The company is an equal opportunities employer and is fair to employees in pay and benefits, health and safety at work, and in the training and personal development offered. It is the aim of the company that our employees, demonstrate the values, attitudes and culture of the company when dealing with each other, our customers, and our stakeholders.

Active steps are taken to ensure that the suggestions, views and interests of staff members are gathered and considered in decision-making.

In common with many businesses, this approach has been manifested in the response to the exigencies of Covid-19, all staff who could and wish to work from home were facilitated therein, whilst those unable or unwilling to work from home were duly catered for in our offices, where an increased emphasis on social distancing, physical barriers and hygiene was implemented and refined. Despite these significant changes and emphasis continued on maintaining controls around standards of business conduct, and on maintaining high levels of employee communication.

-s172(1)(C) The need to foster the company's business relationships with supplies, customers and others

Delivering the company's quality policy requires strong, mutually beneficial relationships with suppliers, customers, and governmental organisations. The company believes in lasting partnerships, founded on shared commitment to quality, value and service.

Examples of commitment to quality include successful negotiation of customer audits of our regulatory compliance, processes and procedures.

-s172(1)(D) the impact of the company's operations on the community and the environment

The that the company must and does play in society is recognised. The company will only succeed by working with customers, governments, suppliers and other stakeholders. An example of this is our compliance procedures (noted above under s172(1)(C)).

-s172(1)(E) The desirability of the company maintaining a reputation for high standards of business conduct.

As a company which seeks to provide high-quality healthcare staff to customers, we are aware of the need to maintain and enhance the reputation of the company for competency and quality and all dealings with stakeholders and customers.

Examples of this are noted elsewhere in this report, which covers s172(1)(C) in reference to customer audits.

Over and above this our policies on modern slavery and any irresponsible business practices are widely promulgated to staff and to customers.

-s172(1)(F) The need to act fairly as between members of the company


ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

STRATEGIC REPORT
FOR THE YEAR ENDED 30 JUNE 2024

All decisions taken seek to ensure fairness between members of the company. The impact of decisions on stakeholders remains a key variable in any and all decision-making.

For example, there remains balancing act between rewards for shareholders (dividend policy), investment in the business, and retention of working capital.

FINANCIAL RISK MANAGEMENT
The company makes little use of financial instruments other than operational bank account and so its exposure to price risk, credit risk, liquidity risk and cash flow risk is not material for the assessment of the assets, liabilities, financial position and profit or loss of the company.

KEY PERFORMANCE INDICATORS
The directors continue to look at key performance indicators ("KPI") such as hours sold, and margins achieved whilst at the same time aiming to actively manage costs and preserve liquidity. Given the nature of the business the company's directors are of the opinion that further analysis using KPI's is not necessary for an understanding of the development, performance, or position of the business.

The directors are aware of the importance of cash flow and treasury management with the result that great emphasis is placed on this.

The directors believe that the company is well placed to achieve its growth targets which include the maintenance of gross margins and positive cash flows.

Key Performance indicator 2024 2023
Gross Profit Margin 25.7% 26.3%
Current Ratio 17.3 8.6

ON BEHALF OF THE BOARD:





I J Ellis - Director


21 March 2025

ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 JUNE 2024


The directors present their report with the financial statements of the company for the year ended 30 June 2024.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of the principal activity of the company continued to be that of healthcare staffing.

DIVIDENDS
No dividends will be distributed for the year ended 30 June 2024.

FUTURE DEVELOPMENTS
Management will continue to seek to drive the business forwards in terms of profitability, client service, market reach and use of technology.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 July 2023 to the date of this report.

I J Ellis
C L Rees
P M Streeter

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 JUNE 2024


AUDITORS
Belluzzo Audit Limited were appointed auditors in the year by the directors and have indicated their willingness to be reappointed for another term and appropriate arrangements have been put in place for them to be deemed reappointed as auditors in the absence of an Annual General Meeting.

ON BEHALF OF THE BOARD:





I J Ellis - Director


21 March 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ARABELLA HEALTH STAFFING LIMITED


Opinion
We have audited the financial statements of Arabella Health Staffing Limited (the 'company') for the year ended 30 June 2024 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).
_
In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30 June 2024 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ARABELLA HEALTH STAFFING LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page five, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ARABELLA HEALTH STAFFING LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities are instances of non-compliance with laws and regulations. The objectives of our audit are to obtain sufficient appropriate audit evidence regarding compliance with laws and regulations that have a direct effect on the determination of material amounts and disclosures in the financial statements, to perform audit procedures to help identify instances of non-compliance with other laws and regulations that may have a material effect on the financial statements, and to respond appropriately to identified or suspected non-compliance with laws and regulations identified during the audit.

In relation to fraud, the objectives of our audit are to identify and assess the risk of material misstatement of the financial statements due to fraud, to obtain sufficient appropriate audit evidence regarding the assessed risks of material misstatement due to fraud through designing and implementing appropriate responses and to respond appropriately to fraud or suspected fraud identified during the audit.

However, it is the primary responsibility of management, with the oversight of those charged with governance, to ensure that the entity's operations are conducted in accordance with the provisions of laws and regulations and for the prevention and detection of fraud.

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud, the audit engagement team:
- obtained an understanding of the nature of the industry and sector, including the legal and regulatory framework that the company operates in and how the company is complying with the legal and regulatory framework;
- inquired of management, and those charged with governance, about their own identification and assessment of the risks of irregularities, including any known actual, suspected or alleged instances of fraud;
- discussed matters about non-compliance with laws and regulations and how fraud might occur including assessment of how and where the financial statements may be susceptible to fraud.

As a result of these procedures we consider the most significant laws and regulations that have a direct impact on the financial statements are FRS 102, the Companies Act 2006 and tax compliance regulations. We performed audit procedures to detect non-compliance which may have a material impact on the financial statements which included reviewing financial statement disclosures and inspecting correspondence with local tax authorities.

The audit engagement team identified the risk of management override of controls and revenue recognition as the areas where the financial statements were most susceptible to material misstatement due to fraud. In respect of management override, audit procedures performed included but were not limited to testing journal entries and other adjustments and evaluating the business rationale in relation to significant, unusual transactions and transactions entered into outside the normal course of business. In respect of revenue recognition, audit procedures performed included but were not limited to tests of control and tests of detail over revenue, and reviewing transactions around the year end to ensure they were recognised in the correct accounting period.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
ARABELLA HEALTH STAFFING LIMITED


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Tony Castagnetti (Senior Statutory Auditor)
Belluzzo Audit Limited Belluzzo Audit Limited
Chartered Accountants and Statutory Auditors
38 Craven Street
London
WC2N 5NG

26 March 2025

ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

INCOME STATEMENT
FOR THE YEAR ENDED 30 JUNE 2024

2024 2023
Notes £    £   

TURNOVER 4 6,207,776 12,347,899

Cost of sales (4,610,578 ) (9,101,255 )
GROSS PROFIT 1,597,198 3,246,644

Administrative expenses (1,484,858 ) (1,606,115 )
OPERATING PROFIT and
PROFIT BEFORE TAXATION 112,340 1,640,529

Tax on profit 7 (25,532 ) (336,241 )
PROFIT FOR THE FINANCIAL YEAR 86,808 1,304,288

ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 JUNE 2024

2024 2023
Notes £    £   

PROFIT FOR THE YEAR 86,808 1,304,288


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

86,808

1,304,288

ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

BALANCE SHEET
30 JUNE 2024

2024 2023
Notes £    £   
CURRENT ASSETS
Debtors 9 9,019,885 9,513,350
Cash in hand 342 342
9,020,227 9,513,692
CREDITORS
Amounts falling due within one year 10 (519,666 ) (1,099,939 )
NET CURRENT ASSETS 8,500,561 8,413,753
TOTAL ASSETS LESS CURRENT
LIABILITIES

8,500,561

8,413,753

CAPITAL AND RESERVES
Called up share capital 11 100 100
Share premium 12 49,900 49,900
Retained earnings 12 8,450,561 8,363,753
SHAREHOLDERS' FUNDS 8,500,561 8,413,753

The financial statements were approved by the Board of Directors and authorised for issue on 21 March 2025 and were signed on its behalf by:





I J Ellis - Director


ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 JUNE 2024

Called up
share Retained Share Total
capital earnings premium equity
£    £    £    £   
Balance at 1 July 2022 100 7,059,465 49,900 7,109,465

Changes in equity
Total comprehensive income - 1,304,288 - 1,304,288
Balance at 30 June 2023 100 8,363,753 49,900 8,413,753

Changes in equity
Total comprehensive income - 86,808 - 86,808
Balance at 30 June 2024 100 8,450,561 49,900 8,500,561

ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024


1. STATUTORY INFORMATION

Arabella Health Staffing Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Financial Reporting Standard 102 - reduced disclosure exemptions
The company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":

-Section 7 'Statement of Cash flows' - Presentation of a statement of cash flow and related notes and disclosures;
- Section 11 ' Basic Financial Instruments' 7 Section 12 'Other Financial instruments Issues' - Carrying amounts, interest income/expense and net gains/losses for each category of financial instrument basis of determining fair value; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes in recognised in profit or loss and in other comprehensive income.
- Section 33 'Related Party disclosures' - Compensation for key management personnel.

The financial statements of the company are consolidated in the financial statements of A24 Group Limited. These consolidated financial statements are available from Companies House.

Significant judgements and estimates
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimates is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover represents amounts receivable for goods and services net of VAT.

Revenue is measured at the fair value of the consideration received or receivable, and represents amounts receivable for the services supplied, stated net of discounts and value added taxes. The company recognizes revenue when the amount of revenue can be reliably measured, when it is probable that the future economic benefits will flow to the company, and when specific criteria have been met for each of the company’s activities.

Income from the placement of temporary agency workers represents the gross sales value of hours worked and is recognised weekly on an accruals basis.

ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024


2. ACCOUNTING POLICIES - continued

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business, represents the difference between the fair value of the consideration payable and the fair value of the separable net assets acquired.

Amortisation is calculated so as to write off the cost of an asset, net of anticipated disposal proceeds, over the estimated useful economic life of ten years.

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.
Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets and liabilities are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the
arrangement constitutes a financing transaction, where the financial instrument is measured as the present value of the future cash flows discounted at a market rate of interest.

Other financial assets
Other financial assets, including trade investments, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024


3. CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY

In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

4. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by class of business is given below:

2024 2023
£    £   
Healthcare staffing 6,207,776 12,347,899
6,207,776 12,347,899

An analysis of turnover by geographical market is given below:

2024 2023
£    £   
United Kingdom 6,207,776 12,347,899
6,207,776 12,347,899

5. EMPLOYEES AND DIRECTORS

There were no employees other than the company's directors during the current and the prior years.
No directors received remuneration from the company in the current and prior year.

2024 2023
£    £   
Directors' remuneration - -

6. OPERATING PROFIT

The operating profit is stated after charging:

2024 2023
£    £   
Hire of plant and machinery - 7,601
Other operating leases 25,592 28,619

The audit fee is paid by the parent company, A24 Group Limited.

ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024


7. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2024 2023
£    £   
Current tax:
Corporation tax 25,532 336,241
Tax on profit 25,532 336,241

UK corporation tax was charged at 19%) in 2023.

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference is explained below:

2024 2023
£    £   
Profit before tax 112,340 1,640,529
Profit multiplied by the standard rate of corporation tax in the UK of 25%
(2023 - 20.500%)

28,085

336,308

Effects of:
Expenses not deductible for tax purposes - (67 )
Adjustments to tax charge in respect of previous periods (2,553 ) -
Total tax charge 25,532 336,241

8. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 July 2023
and 30 June 2024 2,246,376
AMORTISATION
At 1 July 2023
and 30 June 2024 2,246,376
NET BOOK VALUE
At 30 June 2024 -
At 30 June 2023 -

ARABELLA HEALTH STAFFING LIMITED (REGISTERED NUMBER: 05469634)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024


9. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 403,620 516,948
Amounts owed by group undertakings 8,505,188 8,886,437
Prepayments and accrued income 111,077 109,965
9,019,885 9,513,350

Amounts owed by group undertakings are interest free and repayable on demand.

10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 42,314 57,254
Amounts owed to group undertakings 15,353 15,353
Tax 16,848 337,957
Social security and other taxes 110,229 133,580
VAT 66,069 116,782
Other creditors 76,706 20,110
Accruals and deferred income 192,147 418,903
519,666 1,099,939

Amounts due to group undertakings are interest free and repayable on demand.

11. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

12. RESERVES
Retained Share
earnings premium Totals
£    £    £   

At 1 July 2023 8,363,753 49,900 8,413,653
Profit for the year 86,808 86,808
At 30 June 2024 8,450,561 49,900 8,500,461

13. ULTIMATE CONTROLLING PARTY

The immediate and ultimate parent undertaking is A24 Group Limited, a company incorporated in the United Kingdom. Their registered office is 92-96 Lind Road, Sutton, Surrey, SM1 4PL.
A24 Group Limited is the parent of the smallest and largest group of which the company is a member for which group accounts are prepared.
The group accounts can be obtained from Companies House.
At the balance sheet date, the ultimate controlling party was P Streeter.